Serafini Gianluca, Piccinini Giulia, Visimberga Samantha, Cervetti Alice, Belvederi Murri Martino, Monacelli Fiammetta, Pompili Maurizio, Amore Mario
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Section of Psychiatry, University of Genoa, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genoa, Italy,
Psychiatr Danub. 2019 Mar;31(1):26-31. doi: 10.24869/psyd.2019.26.
Aripiprazole is an interesting psychoactive compound acting as a dopamine D2 partial agonist, serotonin 5-HT(1A) partial agonist and serotonin 5-HT(2A) antagonist. Aripiprazole possesses a well-documented efficacy in the treatment of both positive and negative psychotic symptoms. However, this medication may be rarely associated with the onset of hiccup. Here, we present the case of aripiprazole-induced hiccup in a young inpatient at his first psychiatric admission together with a review of the current literature about this topic. The possible etiology underlying the emergence of hiccups together with the clinical implications of this adverse event are discussed.
阿立哌唑是一种有趣的精神活性化合物,它作为多巴胺D2部分激动剂、5-羟色胺5-HT(1A)部分激动剂和5-羟色胺5-HT(2A)拮抗剂发挥作用。阿立哌唑在治疗阳性和阴性精神病性症状方面具有充分记录的疗效。然而,这种药物很少与打嗝的发作有关。在此,我们报告一例年轻住院患者首次因精神疾病入院时出现阿立哌唑诱发打嗝的病例,并对有关该主题的当前文献进行综述。讨论了打嗝出现的可能病因以及这一不良事件的临床意义。